Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Lung (Non-Small Cell)
Study Phase
Phase 3
Study Completion Date
2009
NAUploaded 12-07-2020
Available for Download
PDS UID: LungNo_EliLill_2009_438
Randomized, Open-Label, Phase 3 Study of Pemetrexed plus Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer of Nonsquamous Histology
Files:
PROTOCOLS130_Protocol_Redacted.pdf
CRFS130_CRF_redacted.pdf
DATA DICTIONARYS130_ads_requirement_redacted.pdf
DATA SUMMARYDescriptive_Stats_H3E_US_S130.xlsx
DATA SUMMARYProc Contents Data Dictionary H3E_US_S130.pdf
DATA (COMPARATOR ARM)h3e_us_s130_control_data.zip